Disclosures for "Relapsing and Evolving Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Induced by Nivolumab in a Patient With Hodgkin's Lymphoma in Remission"
-
Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVARTIS. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK.
-
Author has nothing to disclose
-
José Felipe Lacerda Fernandes has nothing to disclose.
-
Author has nothing to disclose
-
Dr. De Siqueira Lima has nothing to disclose.
-
Miss Rodrigues has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Author has nothing to disclose